Skip to main content

Abbott Laboratories (NYSE: ABT) Investor Securities Class Action Lawsuit 08/31/2022

  • If you purchased shares of Abbott Laboratories (NYSE: ABT), you have certain options. NYSE: ABT investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

July 25, 2026 - The case was dismissed.   April 21, 2023 - An amended complaint was filed. August 31, 2022 - An investor in shares of Abbott Laboratories (NYSE: ABT) filed a lawsuit in the U.S. District Court for the Northern District of Illinois over alleged violations of Federal Securities Laws by Abbott Laboratories in connection with certain allegedly false and misleading statemen...



You must register (for free) or login to view the entire case.